Skip to content

CARDIOVASCULAR SYSTEMS, INC.

CIK 0001180145

← back to feed
Revenue (TTM)
$236.48M
−8.8% YoY Q2 Feb 2023
Net Income (TTM)
−$37.14M
−175.2% YoY Q2 Feb 2023
EPS Diluted (TTM)
−$0.95
−168.6% YoY Q2 Feb 2023
Gross Margin
71.2%
Q2 Feb 2023
Operating Margin
-15.9%
Q2 Feb 2023
Net Margin
-15.7%
Q2 Feb 2023
Free Cash Flow (TTM)
−$35.78M
Q2 Feb 2023
Cash
$59.84M
Q2 Feb 2023
Total Debt
$0
Q2 Feb 2023
Shares Outstanding
41.96M sh
Q2 Feb 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings